Xilio Therapeutics is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment. Learn more by visiting www.xiliotx.com and follow us on LinkedIn ( Xilio Therapeutics, Inc .). SUMMARY: The Principal Scientist, CMC Drug Product Development is a crucial role within Technical Operations with the responsibility for technical oversight of the drug product development and manufacturing operations at Xilio Therapeutics. The ideal candidate will have strong technical experience in biologics formulation and drug product development from candidate discovery through IND filing. This role will collaborate with internal cross-functional teams and external project teams and have a key role in supporting the Head of Technical Operations in developing expedited CMC development strategies.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level
Number of Employees
51-100 employees